HKUMed – The University of Hong Kong

What HKUMed – The University of Hong Kong does

HKUMed is the Li Ka Shing Faculty of Medicine of The University of Hong Kong, founded in 1887 and headquartered at 21 Sassoon Road, Pokfulam, Hong Kong. It is a publicly funded, non-profit academic medical institution that delivers medical education (undergraduate MBBS plus MPhil/PhD research postgraduate programmes), biomedical and translational research, and clinical services, the last channeled through the newly branded HKU Health System and six affiliated teaching hospitals (including the cross-border HKU-Shenzhen Hospital).

The faculty's technical and research platform spans cryo-EM and other core facilities, the Centre of Cancer Medicine (established October 2022 with AI-integrated radiation therapy and FLASH research under its ATRO programme), the MB-32 broad-spectrum antiviral co-developed with Tsinghua University, and a leading surgical-innovation programme anchored by the world's first robot-assisted liver transplant. The SUPPORT+ mobile app extends these capabilities into a consumer-facing digital health channel for cancer patients. Research output is highly cited: 70 researchers in the global top 1% by ESI citations, 32 Highly Cited Researchers, and 602 highly cited papers.

HKUMed's revenue model blends four streams: (1) UGC block-grant and government funding from Hong Kong's University Grants Committee; (2) tuition, which is waived for full-time local postgraduates and charged at HK$44,500-63,000 per year for overseas postgraduates; (3) competitive research grants and fellowships (including the Hong Kong PhD Fellowship Scheme); and (4) clinical and contract revenue through the HKU Health System and affiliated hospitals, supplemented by philanthropy and named endowments (notably the Li Ka Shing endowment). Customers are structurally diverse: students and trainees, public-hospital patients routed via the Hospital Authority partnership, research sponsors, and donors.

Name

HKUMed – The University of Hong Kong

Legal name

Li Ka Shing Faculty of Medicine, The University of Hong Kong

Website

https://med.hku.hk

Company type

Private

Founded year

1887

Operating status

Operating

Headcount range

501–1,000 employees

Short description

HKUMed is the medical faculty of the University of Hong Kong, delivering medical education, biomedical research, and clinical services through six affiliated teaching hospitals and the HKU Health System in Hong Kong and Shenzhen.

Ownership category

akta.pro rank

Product category

Medical Education and Research

NAICS

Colleges, Universities, and Professional Schools (6113), General Medical and Surgical Hospitals (622110), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Hospitals (8060)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Medical education
• Biomedical research
• Clinical services
• Medical training
• Healthcare research

Headquarters

HQ city

Hong Kong

HQ country

China

HQ region

Asia

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Government University Funding: Primary funding from Hong Kong University Grants Committee supporting education and research operations
2. Tuition and Composition Fees: Research postgraduate fees: HK$44,500 per annum (2025-26, waived for local full-time students), HK$47,000 (2026-27), HK$49,500 (2027-28 onwards). Part-time: HK$63,000 per annum
3. Research Grants and Fellowships: Hong Kong PhD Fellowship Scheme and various research funding opportunities for postgraduate students and faculty
4. Clinical Services Revenue: Patient care services through HKU Health System network including outpatient clinics and specialist centers at affiliated hospitals
5. Donations and Endowments: Various endowed professorships and donations supporting faculty positions and research (e.g., Danny D B Ho Professor in Family Medicine, 何定邦基金教授席)

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels10 records

Core offering

HKUMed is the Li Ka Shing Faculty of Medicine of The University of Hong Kong, delivering undergraduate and postgraduate medical education, biomedical and clinical research, and clinical services through affiliated teaching hospitals. The faculty operates research postgraduate programs (MPhil/PhD), runs advanced technology platforms (cryo-electron microscopy, PET-CT, MRI, robot-assisted microsurgery), and coordinates patient care via the HKU Health System network spanning six teaching hospitals in Hong Kong and Shenzhen.

Product overview

HKUMed operates as an academic medical institution within The University of Hong Kong, encompassing multiple schools, departments, and research centers. Its primary digital product offering is the SUPPORT+ mobile application, developed by the Department of Clinical Oncology to provide cancer patient support through symptom diaries, health information, and nurse communication features. The institution's technology infrastructure supports clinical services, medical education platforms (EdTech & SIMHSE), and research activities across various medical specialties including robotics-assisted microsurgery, diagnostic imaging, and drug development.

Differentiator

Problem solved

Functional benefit

Brands

• SUPPORT+ (家支援+): Mobile application by Department of Clinical Oncology to support advanced cancer patients and their families in the community with palliative care information and resources
• Centre of Cancer Medicine
• HKU Health System

Products and services

• Research Postgraduate Programmes (MPhil and PhD) Research postgraduate training programs (MPhil and 4-year PhD) in medical and health sciences, including joint PhD programmes with King's College London, University of Toronto, Shenzhen Bay Laboratory, and HKU-Shenzhen Hospital. Targeted at aspiring researchers and clinician-scientists.
• Undergraduate Medical Education Undergraduate medical degree programmes providing foundational medical education and clinical training for prospective doctors. Targeted at secondary school graduates pursuing medical careers.
• HKU Health System Clinical Services Clinical services delivered through HKUMed's network of affiliated teaching hospitals and outpatient clinics, covering diagnostics, specialist consultations, surgical procedures (including robot-assisted microsurgery), oncology, and emergency medicine. Targeted at patients seeking advanced medical care.
• SUPPORT+ (家支援+) Mobile Application A mobile application developed by HKUMed's Department of Clinical Oncology to support advanced cancer patients and their families in the community, offering palliative care information, symptom diaries, health management tools, and nurse communication features. Targeted at cancer patients and caregivers.
• PET-CT and MRI Diagnostic Imaging Services Advanced diagnostic imaging services including PET-CT (since 2007, nearly 20,000 examinations performed) and MRI (1.5T and 3T systems), serving as core facilities for diagnostic imaging and research. Targeted at patients needing advanced imaging and clinical research studies.
• Robot-Assisted Microsurgery Services Precision surgical services using a seven-degrees-of-freedom robot-assisted microsurgery platform enabling surgeons to operate with precision in confined spaces. Includes the world's first robot-assisted liver transplant surgery. Targeted at patients requiring complex micro-surgical procedures.
• Advanced Technology in Radiation Oncology (ATRO) Programme Translational and clinical research programme in advanced radiotherapy technologies including Image Guided Radiation Therapy, 4D Radiation Therapy, IMRT, VMAT, SBRT, SRS, PET-RT, FLASH Radiotherapy, and AI-integrated radiation therapy. Targeted at cancer patients receiving radiotherapy treatment.
• Centre of Cancer Medicine (CancerMed) Holistic academic platform under the School of Clinical Medicine facilitating oncology academic development, integrating cancer prevention, diagnosis, treatment, research and education. Targeted at cancer patients, oncology researchers, and students.

Quantifiable outcome

• Nearly 20,000 PET-CT examinations performed since 2007
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Tsinghua University - School of Pharmaceutical SciencescoreStrategic or Co-development PartnerJoint research team with HKUMed developed MB-32, a first-in-class broad-spectrum small-molecule antiviral drug candidate targeting ACE2. Research published in Nature Communications.
• King's College London (KCL)coreStrategic or Co-development PartnerJoint PhD Programme offering opportunities for students to benefit from shared research excellence between HKU and KCL, with time split equally between both universities.
• University of Toronto (UofT)coreStrategic or Co-development PartnerJoint PhD Programme with time split equally between HKU and UofT, enabling students to access research excellence at both institutions.
• Shenzhen Bay Laboratory (SZBL)coreStrategic or Co-development PartnerShenzhen Bay Laboratory-HKUMed Joint PhD Programme facilitating cross-border research collaboration in biomedical sciences.
• HKU-Shenzhen HospitalcoreStrategic or Co-development PartnerHKU-Shenzhen Hospital PhD Programme and clinical services partnership, providing access to mainland China research landscape and patient population.
• Hong Kong Subsidized Secondary Schools CouncilminorGTM or Marketing PartnerCo-organizer of Hong Kong InnoHealth Cup, a medical innovation competition for secondary school students in Hong Kong and Greater Bay Area.
• Hospital Authority (HA)coreStrategic or Co-development PartnerHA-HKU Dual-Track Appointment Scheme created synergy for medical education, strengthened public hospital manpower, and fostered academic talents in research and innovation. Allows HA doctors to hold adjunct clinical professoriate titles at HKU.
• Queen Mary Hospital (QMH)coreStrategic or Co-development PartnerPrimary teaching hospital partner where robot-assisted microsurgery program was pioneered, including world's first robot-assisted liver transplant surgery.
• Gleneagles Hong Kong HospitalcoreStrategic or Co-development PartnerTeaching hospital partner providing accident and emergency services as part of HKU Health System clinical network.
• Hong Kong Anti-Cancer SocietyminorStrategic or Co-development PartnerSupporting organization for SUPPORT+ cancer patient support mobile application.
• Jockey Club End-of-Life Community Care (JCECC)minorStrategic or Co-development PartnerHKU-based organization providing kind support for SUPPORT+ mobile application.
• Jockey Club Institute of Cancer Care (JCICC)minorStrategic or Co-development PartnerHKU-based organization providing kind support for SUPPORT+ mobile application.

Scale indicators11 records

Recent moves8 records

Expansion highlights8 records

Direct peers

• King's College London Faculty of Life Sciences & Medicine: HKUMed's joint PhD partner and a leading UK medical faculty with strong biomedical sciences and clinical research programs. Comparable in research reputation, international student recruitment, and translational medicine focus.
• Duke-NUS Medical School: Singapore-based graduate-entry medical school with a research-intensive, translational medicine model very similar to HKUMed's postgraduate-heavy research focus. Comparable citation impact and emphasis on clinician-scientist training.
• Sun Yat-sen University Zhongshan School of Medicine: Major mainland medical school with deep Greater Bay Area presence in Guangzhou — a direct regional peer to HKUMed for talent recruitment, clinical training capacity, and GBA medical-education market.
• NUS Yong Loo Lin School of Medicine: Singapore's flagship medical school and HKUMed's closest regional peer in Southeast Asia. Comparable in scale, comprehensive medical training, biomedical research intensity, and affiliated teaching hospital network (NUHS).
• Kyoto University Graduate School of Medicine: Japan's leading medical faculty, known for basic-science research depth. Comparable to HKUMed in research intensity, citation impact, and traditional strength in structural biology, infectious disease, and clinical innovation.
• University of Toronto Temerty Faculty of Medicine: HKUMed's joint PhD partner and one of North America's largest medical faculties. Directly comparable in scale, hospital network (UHN), research intensity, and translational biomedical programs.
• Peking University Health Science Center: Top-tier Chinese medical school combining medical education, biomedical research, and clinical services across affiliated hospitals. Most direct regional competitor to HKUMed in Greater China with comparable scale, comprehensive medical training, and research output.
• Fudan University Shanghai Medical College: One of China's oldest and highest-ranked medical schools, combining comprehensive medical education with affiliated hospital network (Huashan Hospital). Comparable in research output, hospital partnerships, and historical brand.
• Tsinghua University School of Medicine: Research-intensive medical school and active HKUMed partner on the MB-32 antiviral collaboration. Directly comparable in positioning as a fast-rising medical faculty within a top Chinese university, with strong research funding and translational pipelines.
• Seoul National University College of Medicine: South Korea's top medical school and a leading Asian medical faculty. Comparable as a comprehensive research-and-teaching medical institution with affiliated hospital network (Seoul National University Hospital) and similar international research footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/c/HKUMedFac
• Facebookfacebook.com/HKUMed
• LinkedInlinkedin.com/school/hkumed
• Instagraminstagram.com/hkumed

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HKUMed – The University of Hong Kong